Israel: 13% bệnh nhân COVID-19 nhập viện có triệu chứng thần kinh nặng

Trong số hơn 16.000 bệnh nhân mắc COVID-19 nhập viện tại Israel, có tới 13% phát triển các triệu chứng thần kinh nghiêm trọng, phổ biến nhất là bệnh não.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh